Accessibility Menu

Agilent Technologies(FRA) AG8

Market Cap€37.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€132.10
-0.83%
-1.10Today

Agilent Technologies Financials at a Glance

Market Cap

€37.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€6.33K

Net Income (TTM)

€1.24K

EPS (TTM)

€4.36

P/E Ratio

30.53

Dividend

€0.87

Beta (Volatility)

-0.05 (Low)

Price

€132.10

Volume

90

Open

€131.75

Previous Close

€132.10

Daily Range

€130.80 - €132.10

52-Week Range

€94.18 - €137.98

Estimated Earnings Date

N/A

AG8 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Agilent Technologies

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

18,100

CEO

Padraig Mcdonnell

Website

www.agilent.com

AG8 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

20.68%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.28%

Dividend Yield

0.66%

Payout Ratio

N/A

Stock Overview

Market Cap

€37.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

282.43M

Volume

90

Avg. Volume

43.939

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Agilent Technologies Performance Analysis

Agilent Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31EUR 6,419,373,16221.2%
20232023-10-31EUR 6,370,056,820-0.8%
20242024-10-31EUR 5,990,073,351-6.0%
20252025-10-31EUR 6,257,882,6704.5%
Agilent Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31EUR 3.9218.6%
20232023-10-31EUR 3.91-0.3%
20242024-10-31EUR 4.084.4%
20252025-10-31EUR 4.121.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

€1.63K

+1.1%

Gross Profit

€921.63

+1.2%

Gross Margin

56.60%

+1.1%

Market Cap

€37.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.88

N/A

Employees

18,100

N/A

Net Income

€313.86

+1.1%

EBITDA

€443.74

+1.1%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

€4.96K

+14.8%

Total Debt

€3.43K

+1.2%

Accounts Receivable

€1.28K

+1.1%

Inventory

€970.84

+1.1%

Long Term Debt

€3.17K

+1.1%

Short Term Debt

€264.22

+5.1%

Return on Assets

10.84%

+1.0%

Return on Invested Capital

13.98%

+1.1%

Free Cash Flow

€385.01

+1.9%

Operating Cash Flow

€456.35

+1.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About AG8

What is the current price of Agilent Technologies?

Agilent Technologies is trading at €132.10 per share.

What is the 52-week range for Agilent Technologies?

Over the past 52 weeks, Agilent Technologies has traded between €94.18 and €137.98.

How much debt does Agilent Technologies have?

As of the most recent reporting period, Agilent Technologies reported total debt of €3.43B.

How much cash does Agilent Technologies have on hand?

Agilent Technologies reported €1.53B in cash and cash equivalents in its most recent financial results.

What is Agilent Technologies’s dividend yield?

Agilent Technologies currently has a dividend yield of 0.66%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services